| Literature DB >> 33089317 |
Ji Hoon Baang1, Christopher Smith2, Carmen Mirabelli3, Andrew L Valesano1,3, David M Manthei4, Michael A Bachman4, Christiane E Wobus3, Michael Adams2, Laraine Washer1, Emily T Martin5, Adam S Lauring1,3.
Abstract
We describe a case of chronic coronavirus disease 2019 (COVID-19) in a patient with lymphoma and associated B-cell immunodeficiency. Viral cultures and sequence analysis demonstrate ongoing replication of infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for at least 119 days. The patient had 3 admissions related to COVID-19 over a 4-month period and was treated twice with remdesivir and convalescent plasma with resolution of symptoms. The patient's lack of seroconversion and prolonged course illustrate the importance of humoral immunity in resolving SARS-CoV-2 infection. This case highlights challenges in managing immunocompromised hosts, who may act as persistent shedders and sources of transmission.Entities:
Keywords: COVID-19; SARS-CoV-2; antibody; evolution; immunocompromise
Year: 2021 PMID: 33089317 DOI: 10.1093/infdis/jiaa666
Source DB: PubMed Journal: J Infect Dis ISSN: 0022-1899 Impact factor: 5.226